Herbas VPB

Print
EN | LT
LT - METHODS FOR ENGINEERING T CELLS FOR IMMUNOTHERAPY BY USING RNA-GUIDED CAS NUCLEASE SYSTEM
EN - METHODS FOR ENGINEERING T CELLS FOR IMMUNOTHERAPY BY USING RNA-GUIDED CAS NUCLEASE SYSTEM

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C12N 9/22 (2006.01)
C12N 15/63 (2006.01)
C12N 5/0783 (2010.01)
A61P 35/00 (2006.01)
European patent
(11) Number of the document 3309248
(13) Kind of document T
(96) European patent application number 17183472.4
Date of filing the European patent application 2014-04-01
(97) Date of publication of the European application 2018-04-18
(45) Date of publication and mention of the grant of the patent 2021-06-09
(46) Date of publication of the claims translation
Priority applications
(30) Number Date Country code
201370297 2013-05-29 DK
201361888259 P 2013-10-08 US
201361907858 P 2013-11-22 US
201361907874 P 2013-11-22 US
201370771 2013-12-13 DK
PCT/EP2014/051458 2014-01-24 WO
Inventors
(72)
DUCHATEAU, Philippe , FR
CHOULIKA, André , FR
POIROT, Laurent , FR
Grantee
(73) Cellectis , 8 rue de la Croix Jarry, 75013 Paris, FR
Title
(54) METHODS FOR ENGINEERING T CELLS FOR IMMUNOTHERAPY BY USING RNA-GUIDED CAS NUCLEASE SYSTEM
  METHODS FOR ENGINEERING T CELLS FOR IMMUNOTHERAPY BY USING RNA-GUIDED CAS NUCLEASE SYSTEM
Last update date 2021-09-15